Article Text

Download PDFPDF
Pioglitazone reduced MI and acute coronary syndrome but not other cardiovascular events in patients with type 2 diabetes and previous MI

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Source of funding: Takeda Europe R&D Centre Ltd and Eli Lilly and Company.